Enforcing Anti-Monopoly Law Against Big Tech in China: A Case Study of Alibaba’s $2.8bn Fine from SAMR

By: Lerong Lu & Alice Lingsheng Zhang (Oxford Business Law Blog)
Over the past few years, the Chinese authorities have been increasingly concerned about the enormous economic power and influence of the country’s big tech companies, especially those operating in the e-commerce and financial service sectors. On 10 April 2021, the State Administration for Market Regulation (SAMR), which is the Chinese competition watchdog, imposed a record fine of 18.23 billion yuan ($2.8 billion) on the e-commerce giant Alibaba which had abused its market dominance. Alibaba was said to exploit its leading market position, platform policies and data, and algorithmic methods in order to force merchants to sell exclusively on Alibaba Group’s online shopping platforms including Taobao and Tmall. The closing price of NYSE-listed Alibaba was $223.31 on 9 April 2021, down 13% from $256.18 on 23 December 2020 when the anti-monopoly investigation was formally launched. Although the current Anti-Monopoly Law of the People’s Republic of China (PRC) came into effect in 2008, it had never been used to punish leading tech companies and platform economies in the country prior to the Alibaba’s case. Therefore, the anti-monopoly probe is the first of its kind in China, which echoes the global trend of scrutinising the anti-competition activities of big tech corporations like what has happened in the EU and the US. The Alibaba’s fine is equivalent to 4% of the Group’s annual revenue in 2019. In addition, Alibaba was asked by the SAMR to file self-examination and compliance reports to the regulator for the forthcoming three years.
Featured News
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Brazil’s Antitrust Watchdog Expected to Approve Pet Retail Merger Without Conditions
May 20, 2025 by
CPI
EU and UK Finalize Deal to Strengthen Antitrust Cooperation
May 20, 2025 by
CPI
Clemens Food Group Reaches $13.5 Million Settlement in Pork Price-Fixing Suit
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas